This test is most useful if any of these apply to you.
If your blood contains even trace amounts of lead (Pb), your risk of heart disease, stroke, and kidney damage is higher than it should be. There is no safe level. In a study of about 14,300 US adults followed over nearly two decades, researchers estimated that low-level lead exposure contributed to roughly 18% of all deaths and about 29% of cardiovascular deaths in the population studied.
Despite this, lead is not included on any standard blood panel. In a large US healthcare system, only about 0.2% of patients had any lead test over a four-year period. The only way to know your level is to order this test specifically.
Lead is not a nutrient or a molecule your body produces. It is an environmental contaminant that enters through three main routes: breathing in lead-containing dust (especially from old paint or industrial settings), swallowing it (through contaminated water, soil, food, or spices), and occasionally absorbing it through skin contact. Once inside, about 99% binds to your red blood cells, with a tiny fraction circulating freely in the liquid portion of your blood (called plasma).
Your body stores lead in bones for decades, slowly releasing it back into the bloodstream over time. This means your blood lead level reflects both recent exposure and a long-term reservoir. A single blood draw captures what is circulating now, with a half-life of roughly one month. But the lead stored in your skeleton can re-enter your blood during periods of increased bone turnover, such as aging, menopause, or pregnancy.
Lead is a confirmed risk factor for cardiovascular disease, even at levels found in the general population. A large meta-analysis of prospective studies found that lead exposure is associated with a significantly increased risk of cardiovascular disease and coronary heart disease. The evidence is strong enough that recent reviews applying formal causation criteria concluded that the relationship between lead and cardiovascular disease meets the standard for a causal link.
A study of 5,627 Swedish adults found that higher blood lead was linked to greater coronary artery calcium scores, a direct measure of plaque buildup in the heart's arteries, in men. The association followed a dose-response pattern, meaning more lead meant more plaque. Separately, in an analysis of 11,510 Korean adults, those with the highest blood lead had roughly twice the odds of stroke compared to those with the lowest levels. The stroke connection was strongest among people who already had high blood pressure.
The US mortality data from the study of 14,300 adults is striking. Blood lead levels in the 1 to 6.7 µg/dL range, which covers the vast majority of Americans, were linked in a consistent, stepwise fashion to higher rates of death from all causes, cardiovascular disease, and heart attacks specifically. Globally, lead exposure was estimated to have caused approximately 5.5 million cardiovascular deaths in 2019 alone.
The connection between lead and high blood pressure is one of the most consistently documented associations in environmental health. A population-based study of 4,452 adults found that low-level lead exposure was linked to higher systolic and diastolic blood pressure, and may increase the risk of developing hypertension. A systematic review concluded that lead exposure is positively associated with hypertension, with the evidence base supporting a direct effect.
A separate analysis of over 4,400 adults found that blood lead acts as a go-between in the relationship between biological aging and hypertension, meaning that cumulative lead exposure may be one mechanism through which aging raises blood pressure. If you are managing blood pressure and have never checked your lead level, this is a missing piece of the puzzle.
Lead is directly toxic to the kidneys. In a population-based study of 6,908 adults, low-level blood lead was associated with decreased kidney filtration (measured by eGFR, which stands for estimated glomerular filtration rate, a standard gauge of how well your kidneys are cleaning your blood) and an increased rate of chronic kidney disease over time. The relationship held after adjusting for age, sex, smoking, diabetes, and other standard risk factors.
One smaller study of 447 newly hired workers with low-level exposure found no association between blood lead and kidney function measured by creatinine or cystatin C, suggesting that short-term, low-level exposure may not immediately damage the kidneys. The cumulative, long-term exposure reflected in larger population studies is what matters most. This is another reason serial tracking over years, not a single reading, gives you the clearest picture of your risk.
In children, the neurodevelopmental evidence is overwhelming. A scoping review of studies examining blood lead levels below 10 µg/dL in school-age children found consistent associations with lower IQ and higher rates of attention-deficit/hyperactivity disorder (ADHD) diagnoses or behaviors. There is no identified safe threshold. Globally, lead exposure was estimated to have caused the loss of 765 million IQ points in children in 2019.
In a 10-year analysis of over 7,100 people tested for lead in a US healthcare system, children with elevated blood lead had significantly higher rates of new central nervous system diagnoses and new medications afterward. For adults, the same study did not find a clear link between a single blood lead result and subsequent neurological diagnoses, though this likely reflects both shorter follow-up and the subtler nature of adult cognitive effects. Expert reviews note that lead's impact on adult cognition is harder to detect with standard clinical tools but is supported by population-level evidence linking cumulative exposure to cognitive decline.
Lead interferes with the production of hemoglobin, the protein in red blood cells that carries oxygen. This happens because lead blocks enzymes in the heme synthesis pathway, the series of chemical steps your body uses to build hemoglobin. In a study of 751 workers in lead-related manufacturing, cumulative lead exposure was significantly associated with anemia risk. Adopting a workplace blood lead standard of 15 µg/dL rather than 25 µg/dL could reduce anemia risk by 86% to 95% in female workers.
In healthy adults, blood lead is biologically very stable from day to day, with a reproducibility score (intraclass correlation coefficient) of 0.97, meaning that nearly all variation between two draws taken weeks apart reflects real change, not random noise. This makes lead an excellent biomarker for trending: if your number moves, it almost certainly means something has changed in your exposure.
There is no "normal" blood lead level in the way that exists for cholesterol or blood sugar. Any detectable lead represents environmental contamination, not a natural baseline. The ranges below come from US national survey data and occupational health guidelines. They are action thresholds rather than safety zones.
| Blood Lead (µg/dL) | Interpretation | Recommended Action |
|---|---|---|
| Below 3.5 | Below the current CDC reference value for children. In adults, this is the typical range in the general US population. | No immediate action, but this does not mean "safe." Lower is always better. |
| 3.5 to 4.9 | At or above the CDC reference value. Exposure source should be identified. | Confirm with a second venous draw. Investigate household, water, and occupational sources. |
| 5 to 9 | Above the CDC/NIOSH adult reference value. Risk of cardiovascular and kidney harm is clearly elevated. | Minimize exposure. Medical evaluation recommended. Remove from occupational exposure if pregnant. |
| 10 to 19 | Occupational surveillance range. Associated with blood pressure increases and early kidney effects. | Decrease exposure. Quarterly monitoring. Annual lead-focused medical exam. |
| 20 to 29 | Significantly elevated. Clear risk of organ damage. | Remove from exposure if two results are 20 or higher four weeks apart. |
| 30 and above | High. Prompt medical evaluation needed. | Immediate removal from exposure. Consider chelation if symptomatic or above 45 to 50. |
These thresholds come from CDC, NIOSH, and the Council of State and Territorial Epidemiologists (CSTE) occupational guidelines. Your lab may report results in slightly different units. The conversion is: µg/dL multiplied by 0.0483 gives µmol/L. Compare your results within the same lab over time for the most meaningful trend.
At very low blood lead levels (below 5 µg/dL), analytical error can be substantial. US laboratory proficiency rules allow a margin of error up to plus or minus 4 µg/dL for values below 40 µg/dL. In practice, this means a reported result of 4 µg/dL could reflect a true value anywhere from 0 to 8 µg/dL. A study of US clinical laboratories found that 40% could not reliably quantify a sample containing 1.48 µg/dL. If your result is near a decision threshold, always confirm it with a repeat venous draw.
Sample contamination during collection is another common issue, especially for fingerstick (capillary) draws. Lead on the skin can contaminate the sample and produce falsely high results. Venous blood draws are far more accurate and should be used to confirm any elevated capillary result.
Your age, sex, and bone health can also influence the number without a change in recent exposure. Older adults and postmenopausal women may have higher blood lead because bone turnover releases stored lead into the bloodstream. Pregnancy and lactation do the same. If your level changes without an obvious exposure change, bone mobilization is a likely explanation. Common medications such as statins, metformin, and blood pressure drugs have not been shown to meaningfully alter blood lead levels.
Evidence-backed interventions that affect your Lead level
Lead is best interpreted alongside these tests.